Month: April 2026

HAMILTON, Bermuda, April 21, 2026 (GLOBE NEWSWIRE) — S&P Global Ratings (“S&P”) has raised the long-term issuer credit and financial strength ratings on the core insurance operating subsidiaries of SiriusPoint Ltd (“SiriusPoint” or “the Company”) to ‘A’ from ‘A-‘, marking the Company’s third ratings upgrade this year. S&P has also raised its long-term issuer credit rating on the holding company, SiriusPoint Ltd., to ‘BBB+’ from ‘BBB’. The outlook of these ratings is stable. The upgrade reflects S&P’s view that the de-risking of SiriusPoint’s underwriting and investment portfolios, combined with its consistent performance, have “improved its capital position and credit fundamentals significantly.” S&P said: “The rating action also represents our view that the...

NEW YORK, April 21, 2026 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced the launch of the Royalty Pharma Translational Prize, which recognizes exceptional achievements in translational medicine. The Prize will honor scientific breakthroughs that bridge the gap between fundamental discovery and the development of new medicines that improve and extend patients’ lives. It will include a $1 million award distributed among one or more established scientists whose work has translated unique scientific insights into medicines with significant impact, particularly contributions not yet recognized by the field’s most prominent awards. “Royalty Pharma believes that scientific discovery can transform patient lives when it is successfully translated into medicines,” said Pablo Legorreta, Chief Executive Officer and Chairman...

CEDAR RAPIDS, Iowa, April 21, 2026 (GLOBE NEWSWIRE) — United Fire Group, Inc. (Nasdaq: UFCS) (UFG) announced today that its first quarter 2026 earnings results will be released after the market closes on Tuesday, May 5, 2026. An earnings call will be held on Wednesday, May 6, at 9 a.m. CT to allow securities analysts, shareholders and other interested parties the opportunity to hear management discuss the company’s first quarter 2026 results. Teleconference: Dial-in information for the call is toll-free 1-844-492-3723 (international 1-412-542-4184). Participants should request to join the United Fire Group call. The event will be archived and available for digital replay through May 13, 2026. The replay access information is toll-free 1-855-669-9658 (international 1-412-317-0088); access code no. 2049170. Webcast: A webcast...

65 per cent of Canadian say dining out is an important part of their Mother’s Day celebration 1 Nearly a quarter (23%) of moms said they would consider dining alone at a restaurant for part of their Mother’s Day celebrations 1 45 per cent of Canadians think Mother’s Day celebrations for first-time moms should be more special 1TORONTO, April 21, 2026 (GLOBE NEWSWIRE) — As Mother’s Day approaches, Canadians are turning to restaurants to mark the occasion, with 37 per cent planning to celebrate with a meal out this year and 65 per cent saying dining out is an important part of their celebrations.1 To help with the restaurant search, OpenTable has released its annual list of Canada’s Top 100 Brunch and Lunch Restaurants for 2026, highlighting the dining destinations Canadians consistently rate highly for mid-day dining. The list...

ROHM Develops Latest Device of its EcoSiC™ Series:The 5th generation SiC MOSFETs optimized for high-efficiency power applications.Reducing On-Resistance at High Temperatures Compared to Conventional 4th Generation ProductsContributes to making units smaller while increasing output power in high temperature applications.Santa Clara, CA and Kyoto, Japan, April 21, 2026 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced it has developed the latest device of its EcoSiC™ series: the 5th Generation SiC MOSFETs optimized for high‑efficiency power applications. This technology is ideally suitable for automotive electric powertrain systems – such as traction inverters for electric vehicles (xEVs) – as well as power supplies for AI servers and industrial equipment such as data centers. In recent years, the...

Presentation of additional analyses from FAP-Exd (AVA6103) study shows robust activity in PDX models with low FAP expression and more favorable kinetic profile compared to the marketed antibody-drug conjugate (ADC) Enhertu® Dual payload capability of the pre|CISION platform showcased with first in vivo exposure and efficacy data LONDON and PHILADELPHIA, April 21, 2026 (GLOBE NEWSWIRE) — Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION®, a tumor-activated oncology delivery platform, is giving two presentations today at the American Association for Cancer Research (AACR) Annual Meeting 2026.  These presentations include the first in vivo efficacy and exposure pharmacology for the pre|CISION® dual payload technology program and updated...

21 April 2026 Disclosure of trading in own shares under a share buyback program Period: From 13 to 17 April 2026 Issuer’s registered name: Ipsos Issuer’s Identification code: 9695002OY2X35E9X8W87 Financial instrument reference: Ordinary shares – ISIN code FR0000073298 Reporting of transactions in aggregated form (per day and per trading venue)Issuer name Issuer Code Transaction date ISIN Code Daily total volume (in number of shares) Daily weighted average price of shares acquired Platform      ISIN code (ISO 6166)     MIC code (ISO 10383)IPSOS 9695002OY2X35E9X8W87 13-Apr-26 FR0000073298 15 500 36,1261 XPARIPSOS 9695002OY2X35E9X8W87 13-Apr-26 FR0000073298 10 777 36,0545 DXEIPSOS 9695002OY2X35E9X8W87 13-Apr-26 FR0000073298 959 36,0840 TQEIPSOS 9695002OY2X35E9X8W87 13-Apr-26 FR0000073298 1 492 36,0964 AQEIPSOS 9695002OY2X35E9X8W87 14-Apr-26 FR0000073298 16...

                 CENERGY HOLDINGS SA30 Avenue Marnix, 1000 Brussels, Belgium0649.991.654 RLE (Brussels) CONVENING NOTICE TO ATTEND THE ANNUAL ORDINARY SHAREHOLDERS’MEETING TO BE HELD ON 26 MAY 2026 The board of directors of Cenergy Holdings SA (the Company) (the Board of Directors) invites the shareholders to participate to the annual ordinary shareholders’ meeting (the Meeting) to be held on Tuesday, 26 May 2026 at 10.00 a.m. CET at its registered offices, 30 Avenue Marnix, 1000, Brussels, Belgium. AGENDA OF THE MEETINGManagement report of the Board of Directors on the annual accounts of the Company for the accounting year ended 31 December 2025. Report of the statutory auditor on the annual accounts of the Company for the accounting year ended 31 December 2025. Presentation of the consolidated financial statements, the management...

REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that detailed results from the global, randomized Phase 3 RASolute 302 clinical trial evaluating daraxonrasib in patients with previously treated metastatic pancreatic ductal adenocarcinoma (PDAC) will be presented in a Plenary Session at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 – June 2, 2026 in Chicago. Revolution Medicines recently reported an unprecedented overall survival (OS) benefit with daraxonrasib from the RASolute 302 clinical trial. These topline results showed that daraxonrasib taken once daily orally met all primary and key secondary endpoints, demonstrating...